Recovery was one of the only ones not to have suspended his tests on hydroxychloroquine after controversial paper in the Lancet. hydroxychloroquine shows “no
Recovery was one of the only ones not to have suspended his tests on hydroxychloroquine after controversial paper in the Lancet.
hydroxychloroquine shows “no beneficial effect” for the sick of the Covid-19, according to the officials of the clinical trial british Recovery were announced in a press release the judgment in the “immediate” inclusion of new patients for this treatment.
READ ALSO >> Hydroxychloroquine : this is why the study of The Lancet is so criticized
Recovery, clinical trial a major of which the results were very expected, was one of the only ones not to have suspended his tests on hydroxychloroquine after a controversial paper in the Lancet, since withdrawn, that pointed the finger at the inefficiency or even the adverse effect of the molecule controversial.
Your support is essential. Subscribe for $ 1 support Us
mortality rates almost similar
For their study, the researchers Peter Horby and Martin Landray have relied on health data from more than 11 000 patients treated in 175 hospitals in the NHS in the United Kingdom. Every fifteen days, these programmes were reviewed in order to determine if there is evidence strong enough to indicate that hydroxychloroquine affects in a positive way on how to treat the Covid-19.
“We concluded that there was no beneficial effect of hydroxychloroquine in patients admitted to hospital (…) so We decided to stop the registration of participants to the trial Recovery with immediate effect,” write the authors, who have published their findings this Friday.
READ ALSO >> Coronavirus : the WHO announces the resumption of clinical trials with hydroxychloroquine
According to them, there was no significant difference in the primary endpoint of mortality at 28 days (25.7% for patients treated with hydroxychloroquine compared to 23.5% for usual care). The researchers also note that there was no evidence of beneficial effects on the duration of the hospital stay of the patients.
Read our complete file
“Covid-19”, the new coronavirus
Fiasco of The Lancet : “the ‘fast science’, it is even more dangerous than the fast-food” 20 billion of aid : polluting corporations exempt from counterparties ecological? Coronavirus : the WHO changes of doctrine on the use of masks
“These data exclude convincingly all significant benefit of hydroxychloroquine on the mortality observed in patients with the Covid-19”, they concluded. The full results and details of this study will be published in the next few days.
Date Of Update: 05 June 2020, 15:58
Categories: Optical Illusion
Source: newstars.edu.vn